pulmonary arterial hypertension
Conditions
Interventions
None listed
Sponsors
Tohoku University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who had done Treprostinil continuous subcutaneous administration from October 2015 until June 2016.
Exclusion criteria
Exclusion criteria: Not set for the case study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain | — |
Countries
Japan
Contacts
Public ContactChie Myouchin
Tohoku University West 9 Floor
Outcome results
None listed